Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

Why Soleno Therapeutics stock is down today: investor alerts revive Vykat XR scrutiny

New York, Jan 9, 2026, 13:28 (EST) — Regular session Soleno Therapeutics shares slid on Friday, extending a choppy stretch for the rare-disease drugmaker. The stock was down 5.6% at $42.95, after touching a low of $42.73, while the SPDR S&P Biotech ETF was up about 1.1%. The move matters now because Soleno’s story still hinges on a young commercial launch and a single product, Vykat XR. Any shift in sentiment around safety, pricing, or patients staying on therapy can hit the stock hard, fast. A Zacks Equity Research industry outlook on Thursday highlighted Soleno alongside Nektar Therapeutics, Rigel Pharmaceuticals,
Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

Bitcoin price wobbles near $90,000 as ETF outflows bite; Coinbase, Strategy stocks slide

New York, Jan 9, 2026, 13:38 EST — Regular session Bitcoin eased back Friday and was last hovering around $90,700, while crypto-linked stocks such as Coinbase and Strategy slid in the U.S. regular session. Ether fell about 1% and XRP dropped nearly 2%, leaving the broader complex on the back foot after its early-year bounce. The dip carried weight with rates back in the driver’s seat for risk assets, and the latest U.S. jobs report didn’t do much to end the debate. Nonfarm payrolls rose 50,000 in December, short of economists’ 60,000 forecast in a Reuters poll, while the unemployment
Eaton stock rises today as Barclays trims target; CPI and earnings loom

Eaton stock rises today as Barclays trims target; CPI and earnings loom

New York, January 9, 2026, 13:40 EST — Regular session Eaton (ETN.N) shares rose 3.25 points, or about 1.0%, to $323.83 in afternoon trading on Friday, recovering some ground after recent losses. The power-management firm has become a key read-through on spending for electrical gear tied to data centers and grid work, a theme that has swung industrial stocks hard in both directions. Small shifts in the tone around demand can move the group. Eaton fell 3.1% on Wednesday and remains about 19% below its 52-week high of $399.56 hit on July 28, a pullback that has left traders quicker
IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

IREN stock rises as Bernstein calls it a “top AI pick” — what traders watch next

New York, January 9, 2026, 13:27 (EST) — Regular trading session IREN Limited shares climbed about 4.6% on Friday to $47.76, adding to a choppy start to the year for the bitcoin miner turned AI data-center play. In heavy volume, the stock swung between a high of $49.99 and a low of $45.52. The move matters because IREN has turned into a quick proxy for two trades at once: crypto-linked cash flow and demand for AI compute. When either narrative shifts, the stock usually moves first and asks questions later. Bernstein analyst Gautam Chhugani told investors to “start 2026 by
Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

Wave Life Sciences (WVE) stock slides 6% even as biotech ETFs rise — what’s driving it now

New York, January 9, 2026, 13:20 (EST) — Regular session Wave Life Sciences Ltd shares fell about 5.6% on Friday, down 83 cents at $14.00, after trading between $13.99 and $15.09. The drop came even as biotech exchange-traded funds rose, with the SPDR S&P Biotech ETF up about 1% and the iShares Nasdaq Biotechnology ETF up about 0.5%. The move matters because Wave has become a high-beta obesity trade in the biotech tape, and the stock has been swinging on every new data point and funding headline. Traders have been leaning on near-term catalysts rather than fundamentals, and those catalysts
Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

NEW YORK, Jan 9, 2026, 13:32 (EST) — Regular session Applied Materials Inc (AMAT) shares jumped about 6% on Friday, at one point topping $300, as chip-equipment names moved higher. AMAT was up 6% at $298.53 in afternoon trading. Lam Research rose about 8%, KLA was up about 5% and ASML added about 6%, while the iShares Semiconductor ETF gained nearly 3%. The gain came after strong figures from Taiwan Semiconductor Manufacturing Co, the world’s biggest contract chipmaker. TSMC said fourth-quarter revenue climbed 20.45% from a year earlier to T$1.046 trillion, beating a market forecast. It will lay out its
Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

Reddit stock slides after Cantor starts coverage at Neutral and CFO sale hits filings

New York, Jan 9, 2026, 13:16 ET — Regular session Reddit, Inc shares fell 5.8% to $239.12 in afternoon trading on Friday, reversing an early push above $260. The move matters because Reddit stock has been priced like a fast grower, and fresh coverage is starting to draw harder lines around what that growth is worth. With results for the holiday quarter still ahead, even a “nothing’s broken” call can jolt a name trading at a premium. U.S. stocks were higher after a softer December jobs report, leaving Reddit as an outlier on the tape. The Nasdaq Composite was up
Oddity Tech stock drops nearly 6% after Oddity Labs science chief exit, KeyBanc trims target

Oddity Tech stock drops nearly 6% after Oddity Labs science chief exit, KeyBanc trims target

New York, Jan 9, 2026, 13:11 EST — Regular session Oddity Tech Ltd shares fell 5.8% to $36.28 on Friday, extending a sharp pullback for the beauty and wellness company as investors weighed a senior departure at its research unit and a fresh price-target cut. The stock opened higher but swung between $35.80 and $38.82. In a Form 6-K filing with U.S. regulators — a report foreign-listed companies use to disclose material updates — Oddity said Dr. Ido Bachelet is no longer employed with the company. Bachelet had served as chief science officer of ODDITY LABS, and his duties have
CoreWeave stock rises after insiders disclose $21 million in share sales

CoreWeave stock rises after insiders disclose $21 million in share sales

New York, Jan 9, 2026, 13:19 EST — Regular session CoreWeave shares rose nearly 3% on Friday, extending a choppy start to the year for the AI cloud firm, after filings showed its chief executive and a top lieutenant sold about $20.7 million worth of stock earlier this week. (SEC) The sales matter because CoreWeave is still a relatively new listing and the stock can swing on signs of extra supply — especially when it comes from senior executives. CoreWeave, founded in 2017, listed on Nasdaq in March 2025 under the symbol CRWV. (CoreWeave) The broader tape was firmer, with
Under Armour stock drops 6% as BlackRock reveals 10.6% stake in UAA

Under Armour stock drops 6% as BlackRock reveals 10.6% stake in UAA

NEW YORK, Jan 9, 2026, 13:03 ET — Regular session Under Armour’s voting Class A shares (UAA) sank roughly 6% on Friday after a disclosure showed BlackRock owned more than a tenth of the sportswear maker. The stock was off 6.1% at $5.64 by midday, after moving in a range of $6.10 to $5.61. The timing is awkward for Under Armour. The company is in reset mode, and the stock has started getting jumpy again. Big ownership updates can squeeze the “tradable” float — shares that actually change hands day to day — and that can make price swings sharper.
UnitedHealth (UNH) stock slips as House sets CEO hearing and Senate deadline looms

UnitedHealth (UNH) stock slips as House sets CEO hearing and Senate deadline looms

New York, Jan 9, 2026, 12:57 EST — Regular session UnitedHealth Group shares edged lower Friday after leaders of a U.S. House committee set a Jan. 22 hearing that will summon CEO Stephen Hemsley to Capitol Hill. The stock fell 0.7% to $344.30 by midday, and CVS Health, Cigna and Elevance were also down. The timing matters. Washington is turning the spotlight back on health insurers right as investors gear up for a busy stretch of earnings and guidance, when companies usually put numbers around medical costs and pricing. UnitedHealth has its own deadline coming up. The company is set
Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

Gold price today: 24K jumps to ₹137,122/10g, silver back above ₹242,000/kg after whipsaw

NEW DELHI, January 9, 2026, 23:22 IST India’s benchmark gold and silver rates jumped on Friday, lifting bullion back toward recent highs after Thursday’s slide. The India Bullion and Jewellers Association (IBJA), an industry body that publishes benchmark bullion prices, put its PM rate for 24-carat gold (999 purity) at 137,122 rupees per 10 grams, up 1,349 rupees on the day, while silver (999) rose 6,982 rupees to 242,808 rupees per kg. IBJA rates are quoted before India’s goods and services tax (GST) and before jewellers add making charges. (ibjarates.com) The move matters because it keeps domestic prices pinned near

Stock Market Today

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

7 February 2026
Singapore, Feb 7, 2026, 15:29 SGT — Market closed. Jardine Matheson Holdings fell 2.4% on Friday to close at $75.71 in its U.S. dollar counter on the Singapore Exchange, after trading between $75.30 and $78.83. About 293,900 shares changed hands, compared with 410,700 a day earlier. (Yahoo Finance) The move landed as regional markets cooled on a tech-led selloff and broader de-risking. Singapore’s shares fell 0.8% on the day, while investors tracked turbulence tied to U.S. tech and fresh debate over how quickly new AI tools could reshape software and services. “With U.S. tech wobbling, sentiments tend to trickle over
CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop